Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital
1997

Second Malignancy Risks in Hodgkin's Disease Patients

Sample size: 1039 publication Evidence: high

Author Information

Author(s): AJ Swerdlow, JA Barber, A Horwich, D Cunningham, S Milan, RZ Omar

Primary Institution: Royal Marsden Hospital

Hypothesis

Does treatment for Hodgkin's disease increase the risk of second malignancies?

Conclusion

Patients treated for Hodgkin's disease have a significantly increased risk of developing second malignancies, particularly solid cancers.

Supporting Evidence

  • 77 second malignancies occurred among the cohort.
  • Significantly raised risks were found for stomach, lung, bone, soft tissue, and non-melanoma skin cancers.
  • Leukaemia risk was significantly raised in patients receiving chemotherapy.
  • The relative risk of second cancers was much greater in patients treated at younger ages.

Takeaway

Kids who get treated for Hodgkin's disease might get sick again later with different types of cancer, especially if they were younger when they were treated.

Methodology

Data was collected from 1039 patients treated for Hodgkin's disease from 1963 to 1991, with follow-up for second malignancies until June 1991.

Potential Biases

Potential biases may arise from the retrospective nature of the study and reliance on cancer registry data.

Limitations

The study may not account for all variables affecting cancer risk, and some patients were excluded due to incomplete follow-up.

Participant Demographics

649 men and 390 women, mostly under 45 years old at first treatment.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% Cl

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication